Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
EHC
HALO
Add up to 3 more stocks
EHC
Encompass Health Corporation
+2.90%
$124.48+3.51Delayed quote: Oct 6, 2026, 1:40 PM EDT
Market Cap
$12.35B
52W Range
$92.77 - $127.99
HALO
Halozyme Therapeutics, Inc.
+1.60%
$110.05+1.74Delayed quote: Oct 6, 2026, 1:40 PM EDT
Market Cap
$13.05B
52W Range
$61.23 - $116.85
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 20.27 | 32.85 |
| Forward P/E | 20.36 | 13.08 |
| PEG Ratio | 1.43 | 1.43 |
| P/B Ratio | 4.75 | 90.93 |
| P/S Ratio | 1.99 | 7.85 |
| P/FCF Ratio | 29.87 | 16.19 |
| EV/EBITDA | 10.31 | 14.25 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 95.7% | 78.2% |
| Operating Margin | 18.0% | 56.8% |
| Net Margin | 10.0% | 24.9% |
| ROE | 23.9% | 288.1% |
| ROA | 8.3% | 16.1% |
| ROIC | 13.4% | 27.4% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.19 | 2.71 |
| Quick Ratio | 1.19 | 2.31 |
| Debt/Equity | 1.09 | 14.95 |
| Interest Coverage | 8.55 | 45.03 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 0.6% | N/A |
| Payout Ratio | 12.4% | N/A |
| Yrs of Dividend Growth | 2 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.